Maja Agung Latexindo Valuation

Is SURI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SURI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SURI's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SURI's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SURI?

Key metric: As SURI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SURI. This is calculated by dividing SURI's market cap by their current earnings.
What is SURI's PE Ratio?
PE Ratio	106.8x
Earnings	Rp5.10b
Market Cap	Rp519.42b

SURI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.8x
Enterprise Value/EBITDA	318.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does SURI's PE Ratio compare to its peers?

The above table shows the PE ratio for SURI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	43.9x
HALO Haloni Jane	85.7x	n/a	Rp378.6b
OMED Jayamas Medica Industri	16.7x	9.7%	Rp4.8t
IRRA Itama Ranoraya	62.5x	n/a	Rp624.2b
PEVE PT. Penta Valent	10.7x	n/a	Rp441.4b
SURI Maja Agung Latexindo	106.8x	n/a	Rp519.4b

Price-To-Earnings vs Peers: SURI is expensive based on its Price-To-Earnings Ratio (106.8x) compared to the peer average (43.9x).

Price to Earnings Ratio vs Industry

How does SURI's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: SURI is expensive based on its Price-To-Earnings Ratio (106.8x) compared to the Asian Medical Equipment industry average (26.5x).

Price to Earnings Ratio vs Fair Ratio

What is SURI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SURI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	106.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SURI's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.